DrugBank: Funding, Investors & Team (Sep 2026)
DrugBank enhances human intelligence in order to improve global health. Our range of products relies on the most comprehensive and up-to-date database of pharmaceutical knowledge in the world. This database covers all aspects of drugs and their mechanisms within the body. We offer healthcare companies the opportunity to enhance their services through precision medicine and clinical software applications. Additionally, we help uncover valuable insights through the use of data science in drug discovery. Our knowledge base can be seamlessly integrated into software solutions to support clinical intelligence. Companies can easily expand their usage through our API and launch their products faster using flexible data modules. By providing users with advanced insights and timely information, we empower them to make better decisions regarding their health. Our extensive and well-organized datasets are utilized for various purposes, such as discovering new drug candidates, identifying opportunities for drug repurposing, and constructing predictive machine learning models. For companies engaged in data science, our evidence-based drug information allows for quick answers and accelerated drug development. Lastly, our publicly accessible resource, DrugBank Online, is available for free and offers limited datasets for download to academic and non-commercial researchers. DrugBank has been referenced in over 13,000 academic publications and is trusted by millions of researchers and health professionals worldwide.
DrugBank has raised $7.8M across 2 funding rounds on record, the most recent an undisclosed round of $720k announced in Aug 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
DrugBank Company Profile and Key Stats
Latest funding round on record: Aug 2023.
DrugBank Funding Rounds
DrugBank raised $7.1M in a Seed announced in Apr 2022.
1.3 years later, an undisclosed round of $720k was announced in Aug 2023.
DrugBank Founders and Leadership Team
No contact details are on record for this team yet.
DrugBank Funding Compared to Other Biotechnology Startups
DrugBank's latest round of $720k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like DrugBank in Biotechnology and Edmonton
Companies Similar to DrugBank
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
DrugBank Funding FAQs
What does DrugBank do?
DrugBank enhances human intelligence in order to improve global health. Our range of products relies on the most comprehensive and up-to-date database of pharmaceutical knowledge in the world. This database covers all aspects of drugs and their mechanisms within the body. We offer healthcare companies the opportunity to enhance their services through precision medicine and clinical software applications. Additionally, we help uncover valuable insights through the use of data science in drug discovery. Our knowledge base can be seamlessly integrated into software solutions to support clinical intelligence. Companies can easily expand their usage through our API and launch their products faster using flexible data modules. By providing users with advanced insights and timely information, we empower them to make better decisions regarding their health. Our extensive and well-organized datasets are utilized for various purposes, such as discovering new drug candidates, identifying opportunities for drug repurposing, and constructing predictive machine learning models. For companies engaged in data science, our evidence-based drug information allows for quick answers and accelerated drug development. Lastly, our publicly accessible resource, DrugBank Online, is available for free and offers limited datasets for download to academic and non-commercial researchers. DrugBank has been referenced in over 13,000 academic publications and is trusted by millions of researchers and health professionals worldwide.
How much funding has DrugBank raised?
DrugBank has raised $7.8M across 2 rounds on record. The most recent is an undisclosed round of $720k announced in Aug 2023.
When did DrugBank last raise funding?
DrugBank's most recent funding round on record is an undisclosed round of $720k, announced in Aug 2023.
Who is the CEO of DrugBank?
Michael Wilson is listed as CEO at DrugBank.
Where is DrugBank headquartered?
DrugBank is based in Edmonton, Alberta, Canada.
How many employees does DrugBank have?
DrugBank is in the 51-100 employee band.
How does DrugBank's funding compare to other Biotechnology startups?
DrugBank's latest round of $720k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's DrugBank Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for DrugBank is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.